Skip to main content

José Alegre Martin

Institutions of which they are part

Rheumatology
Vall Hebron Institut de Recerca

José Alegre Martin

Institutions of which they are part

Rheumatology
Vall Hebron Institut de Recerca

Projects

Estratificación de la severidad de la fatiga en el síndrome de COVID persistente: nuevas estrategias terapéuticas

IP: José Alegre Martin
Collaborators: PATRICIA LAUNOIS OBREGÓN, Ramón Sanmartín Sentañes
Funding agency: Fundación Invest. Médica Mutua Madrileña
Funding: 109998
Reference: MUTUA_MADRILEÑA/2022/ALEGRE
Duration: 20/07/2022 - 19/07/2025

Disfunción autonómica y ritmo circadiano en el Síndrome de Fatiga Crónica/Encefalomielitis Miálgica: nuevas herramientas diagnósticas y terapéuticas en la enfermedad

IP: José Alegre Martin
Collaborators: Jesus Castro Marrero, Jesus Castro Marrero, Jesus Castro Marrero, Jesus Castro Marrero, Jesus Castro Marrero, Jesus Castro Marrero, Jesus Castro Marrero, Jesus Castro Marrero
Funding agency: Instituto de Salud Carlos III
Funding: 87120
Reference: PI19/00629
Duration: 01/01/2020 - 30/06/2024

Development, dIagnostic and prevention of gender-related Somatic and mental COmorbitiEs in IRritable bowel syndrome In Europe (DISCOvERIE)

IP: Fco Javier Santos Vicente
Collaborators: Beatriz Lobo Alvarez, Silvia Muñoz Caller, Carmen Alonso Cotoner, Natalia Rodriguez Santas, Ana Maria Gonzalez Castro, Elba Exposito Fernandez, Marc Pigrau Pastor, Adoración Nieto Ruiz, Alejandro Henao Paez, Consuelo Cammarota, José Alegre Martin, Jesus Castro Marrero, Marta Ribases Haro, Natalia Llonga Tejedor, Amanda Rodríguez Urrutia
Funding agency: EUROPEAN COMMISSION
Funding: 1148684.84
Reference: DISCOVERIE_H2020-SC1-BHC2019
Duration: 01/01/2020 - 31/05/2025

European Network on Myalgic Encephalomyelitis / Chronic Fatigue Syndrome (EUROMENE)

IP: Jesus Castro Marrero
Collaborators: José Alegre Martin
Funding agency: EUROPEAN COMMISSION
Funding: 52000
Reference: EUROMENE_CA15111_COST2015
Duration: 21/04/2016 - 20/04/2020

Related news

Transaction expands Formation Bio's immunology pipeline with Phase 1 ready drug candidate.

15 researchers from the Rheumatology, Systemic Diseases and the Physiology and Pathophysiology of the Digestive Tract groups gave around 25 presentations.

Funded by the European Union, this project coordinated by the Vall d'Hebron Research Institute (VHIR) seeks to develop more effective therapies by creating new combinations of existing drugs

Related professionals

Cristina Avila Fumanal

Cristina Avila Fumanal

Growth and Development
Read more
Mireia  Beltran  Porres

Mireia Beltran Porres

Growth and Development
Read more
Laia Closa Gil

Laia Closa Gil

Postdoctoral researcher
Transfusional Medicine
Read more
Sandra Rojas Nieto

Sandra Rojas Nieto

Shock, Organ Dysfunction and Resuscitation
Read more

Subscribe to our newsletters and be part of the Campus life

We are a world-leading healthcare complex where healthcare, research, teaching and innovation go hand in hand.

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.